TA
XERS icon

Teachers Advisors’s Xeris Biopharma Holdings XERS Stock Holding History

Teachers Advisors’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$283K Buy
+28,196
New +$361K ﹤0.01% 2746

Other funds holding XERS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Teachers Advisors's XERS Position: Q1 2019 in Review

Teachers Advisors opened a new position in Xeris Biopharma Holdings (XERS) in Q1 2019: 28,196 shares worth $283K. The stake represents ﹤0.01% of the portfolio and ranks #2746 among its holdings.

49 funds tracked by Wall St. Rank hold XERS as of Q1 2019.

  • Teachers Advisors held 28,196 shares of Xeris Biopharma Holdings worth $283K as of Q1 2019.
  • Xeris Biopharma Holdings was a new Teachers Advisors position in Q1 2019.
  • Xeris Biopharma Holdings made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2746 holding.
  • 49 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.